Skip to Content

Investor Relations

BioScrip®, Inc. is the largest independent national provider of infusion and home care management solutions, with approximately 2,200 teammates and nearly 80 service locations across the U.S...
Read More

Corporate Profile

BioScrip®, Inc. is the largest independent national provider of infusion and home care management solutions, with approximately 2,200 teammates and nearly 80 service locations across the U.S. BioScrip partners with physicians, hospital systems, payors, pharmaceutical manufacturers and skilled nursing facilities to provide patients access to post-acute care services. BioScrip operates with a commitment to bring customer-focused pharmacy and related healthcare infusion therapy services into the home or alternate-site setting. By collaborating with the full spectrum of healthcare professionals and the patient, BioScrip provides cost-effective care that is driven by clinical excellence, customer service, and values that promote positive outcomes and an enhanced quality of life for those it serves.

Investor Overview

News Releases

Date Title and Summary
Toggle Summary BioScrip Acquires Intravenous Therapy Services; Establishes West Coast Platform for Specialty Infusion Operations; BioScrip Increases Existing Credit Facility to $65 Million
ELMSFORD, N.Y.--(BUSINESS WIRE)--March 2, 2006--BioScrip, Inc. (NASDAQ: BIOS) today announced that it has acquired Intravenous Therapy Services ("ITS"), a specialty infusion company located in Burbank, California. In addition, the Company announced that it has increased its existing revolving
Toggle Summary BioScrip Acquires Northland Pharmacy; Expands Community Pharmacy Model
ELMSFORD, N.Y. & MINNEAPOLIS, Oct 11, 2005 (BUSINESS WIRE) -- BioScrip, Inc. (NASDAQ:BIOS) today announced that it has acquired Northland Medical Pharmacy ("Northland"), a community-based specialty pharmacy, located in Columbus, Ohio. Henry F. Blissenbach, BioScrip's President and Chief Executive
Toggle Summary BioScrip and Home Solutions Enter Into Amended Agreement
Amendment Further Enhances Value for Shareholders Accretive Transaction Provides Substantial Operating Synergies and Deleveraging Opportunity DENVER and HAMMONTON, N.J., June 16, 2016 (GLOBE NEWSWIRE) -- BioScrip, Inc. (NASDAQ:BIOS) ("BioScrip" or the "Company"), a leading national provider of